115 related articles for article (PubMed ID: 12204666)
1. Quality assurance in the EORTC 22921 trial on preoperative radiotherapy with or without chemotherapy for resectable rectal cancer: evaluation of the individual case review procedure.
Kouloulias VE; Bosset JF; van Tienhoven G; Davis BJ; Pierart M; Poortmans P;
Eur J Cancer; 2002 Sep; 38(14):1849-56. PubMed ID: 12204666
[TBL] [Abstract][Full Text] [Related]
2. Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy-run.
Widder J; Sedlmayer F; Stanek C; Pötter R
Radiother Oncol; 2000 Sep; 56(3):341-7. PubMed ID: 10974384
[TBL] [Abstract][Full Text] [Related]
3. Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review.
Ataman F; Poortmans P; Stupp R; Fisher B; Mirimanoff RO
Eur J Cancer; 2004 Jul; 40(11):1724-30. PubMed ID: 15251162
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
7. Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.
Hurkmans CW; Borger JH; Rutgers EJ; van Tienhoven G; ;
Radiother Oncol; 2003 Sep; 68(3):233-40. PubMed ID: 13129630
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run.
Versteijne E; Lens E; van der Horst A; Bel A; Visser J; Punt CJA; Suker M; van Eijck CHJ; van Tienhoven G
Strahlenther Onkol; 2017 Aug; 193(8):630-638. PubMed ID: 28608305
[TBL] [Abstract][Full Text] [Related]
9. Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group.
van Tienhoven G; van Bree NA; Mijnheer BJ; Bartelink H
Radiother Oncol; 1991 Dec; 22(4):290-8. PubMed ID: 1792323
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary--medial supraclavicular irradiation in stage I-III breast cancer: the individual case review.
Poortmans P; Kouloulias VE; Venselaar JL; Struikmans H; Davis JB; Huyskens D; van Tienhoven G; Hurkmans C; Mijnheer B; Van den Bogaert W
Eur J Cancer; 2003 Sep; 39(14):2035-42. PubMed ID: 12957458
[TBL] [Abstract][Full Text] [Related]
11. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a Quality Assurance Review Center-Pediatric Oncology Group study.
Halperin EC; Laurie F; Fitzgerald TJ
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):1001-4. PubMed ID: 12095569
[TBL] [Abstract][Full Text] [Related]
13. Preoperative radiotherapy in rectal carcinoma--aspects of acute adverse effects and radiation technique.
Frykholm GJ; Isacsson U; Nygård K; Montelius A; Jung B; Påhlman L; Glimelius B
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):1039-48. PubMed ID: 8751414
[TBL] [Abstract][Full Text] [Related]
14. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.
Bosset JF; Calais G; Daban A; Berger C; Radosevic-Jelic L; Maingon P; Bardet E; Pierart M; Briffaux A;
Eur J Cancer; 2004 Jan; 40(2):219-24. PubMed ID: 14728936
[TBL] [Abstract][Full Text] [Related]
15. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
[TBL] [Abstract][Full Text] [Related]
16. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.
Bosset JF; Calais G; Mineur L; Maingon P; Radosevic-Jelic L; Daban A; Bardet E; Beny A; Briffaux A; Collette L
J Clin Oncol; 2005 Aug; 23(24):5620-7. PubMed ID: 16009958
[TBL] [Abstract][Full Text] [Related]
17. Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview.
van Tienhoven G; Mijnheer BJ; Bartelink H; González DG
Strahlenther Onkol; 1997 Apr; 173(4):201-7. PubMed ID: 9111608
[TBL] [Abstract][Full Text] [Related]
18. Variability of target volume delineation in cervical esophageal cancer.
Tai P; Van Dyk J; Yu E; Battista J; Stitt L; Coad T
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):277-88. PubMed ID: 9788405
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
20. [Concomitant preoperative radiochemotherapy for rectal cancers].
Bosset JF; Pelissier EP; Mantion G; Horiot JC; Pavy JJ
Ann Chir; 1996; 50(4):302-10; discussion 311. PubMed ID: 8758519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
